Spots Global Cancer Trial Database for Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
Official Title: Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
Study ID: NCT05737368
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety and effectiveness in the treatment of recurrent glioblastoma with Cadonilimab combined with fractionated radiotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Qichun Wei, MD/PhD
Affiliation: Zhejiang University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
